Results 111 to 120 of about 12,647 (196)

Complement Alternative Pathway Dominance in Atypical Hemolytic Uremic Syndrome Revealed by Endothelial Bioassays. [PDF]

Kidney Int Rep
Santarsiero D, Gastoldi S, Guaschino V, Bresin E, Pagani I, Pasini A, Romano E, Benigni A, Remuzzi G, Noris M, Aiello S.   +10 more
europepmc   +1 more source

Atypical Hemolytic Uremic Syndrome

Journal of Allergy and Clinical Immunology
Patrick R. Walsh, David Kavanagh
openaire   +2 more sources

Update in the diagnosis of complement-mediated thrombotic microangiopathy/atypical hemolytic uremic syndrome. [PDF]

Hematology Am Soc Hematol Educ Program
Cole MA.
europepmc   +1 more source

Malignant Hypertension-Induced Thrombotic Microangiopathy Mimicking Atypical Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura. [PDF]

JACC Case Rep
Valdez-Thomas M, Carrasquel-Alvarez M, Acosta MDP, Hurtado-Leon YJ, Quintanilla MS, Khanal S.   +5 more
europepmc   +1 more source

Eculizumab cessation in atypical hemolytic uremic syndrome [PDF]

Blood, 2017
Samuel A, Merrill, Zachary D, Brittingham, Xuan, Yuan, Alison R, Moliterno, C John, Sperati, Robert A, Brodsky   +5 more
openaire   +2 more sources

Efficacy of eculizumab discontinuation in atypical hemolytic uremic syndrome: a systematic review and meta-analysis. [PDF]

Blood Adv
Hockman A, Anuskiewicz S, Brennan E, Chowdhury SR, Coltoff A, Poston JN, Greenberg C, Djulbegovic B.   +7 more
europepmc   +1 more source

Importance of case age in the purported association between phylogenetics and hemolytic uremic syndrome in Escherichia coli O157:H7 infections [PDF]

, 2018
Besser, T.E., Mayer, J., Oltean, H.N., Phipps, A.I., Rabinowitz, P., Shringi, S., Tarr, G.A.M., Tarr, P.I., Wakefield, J.   +8 more
core   +1 more source

Early recognition of atypical hemolytic uremic syndrome to prevent irreversible kidney injury: cardiac failure and refractory hypertension as critical clues in young patients. [PDF]

CEN Case Rep
Tsiamis N, Kole C, Stefanou E, Tountas C, Theodoros H, Liapis G, Kitsiou A.   +6 more
europepmc   +1 more source

Iptacopan in C5 blockade refractory atypical hemolytic uremic syndrome with associated Castleman's disease: case report. [PDF]

BMC Nephrol
Nguyen MD, Ciurea S, Desai S, Kalebasty AR, Tran MH, Gee C, Tadros M, Nguyen VQ, Patel S, Selamet U, Hanna R.   +10 more
europepmc   +1 more source

Antifactor H Autoantibody Characterization in Atypical Hemolytic Uremic Syndrome. [PDF]

Kidney Int Rep
Dulipati V, Kaskinen A, Lokki AI, Kotimaa J, Messing M, Tainio J, Räisänen-Sokolowski A, Jahnukainen T, Meri S.   +8 more
europepmc   +1 more source